Quince Therapeutics, Inc.
QNCXCIK 0001662774 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K filed Apr 10, 2026. Sentiment + YoY language diff vs prior year. Read sections →
Signal:NeutralFull-doc fallback
Full filing:tone -0.0196
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Quince Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Holsinger Leslie | Officer | 3 |
| McDowell Caryn Gordon | Officer | 3 |
| Patni Rajiv | Director | 3 |
| Smith Karen L. | Officer | 3 |
| Detke Michael J. | Officer | 2 |
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at Quince Therapeutics, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | Hannah Brendan | 6 | 100% | +181.7% | +181.7% | +186.9% | +176.6% |
All filings
96 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|